Seroatlas · Human Serome Atlas

CYP2G1P

Putative inactive cytochrome P450 2G1

Also known as: C2G1P_HUMAN

Cross-references: UniProt · GeneCards · NCBI Gene

Protein identityUniProt · HPA

UniProt accession: Q6ZSU1
Gene: CYP2G1P
Canonical length: 146 aa

OverviewNCBI Gene

No narrative summary is available for CYP2G1P in this catalog release; identity and structured annotations are shown without generated factual claims.

Canonical amino-acid sequenceUniProt

146 residues, UniProt reviewed canonical sequence.

>Q6ZSU1|CYP2G1P
     1  MPYTDVVIHE IQRLVDIVPM GVPHNIIQDT QFRGYLLPKG TDVFPLLGSV LKDPKYFRYP
    61  DAFYPQHFLD EQGRFKKNEA FVPFSSGKRI CLGEAMARME LFLYFTSTLQ NFSLCSLVPL
   121  VDIDITPKLS GFGNITPTYE LCLVAR

LocalizationUniProt · AlphaFold · HPA

Whether an antibody against CYP2G1P can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.

Antibody reachability: Unknown
Secreted: No
Transmembrane segments: 0
Mean surface accessibility (rSASA): 0.38

OntologyGO

Molecular functions

Protein domainsUniProt · Pfam · InterPro

KeywordsUniProt

Antibody and autoantibody relevanceSeroatlas analysis

Seroatlas reads CYP2G1P as an antibody target. Whether an autoantibody or antibody against CYP2G1P could matter depends on whether native CYP2G1P is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.

CYP2G1P is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.

Annotation status

The present source text does not explicitly label CYP2G1P as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.

Loading the interactive Seroatlas protein explorer...